PF285 ZELLA-101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

Autor:	D. Lee, J. Zeidner, M. Frattini, B. D. Smith, D. Bearss, S. Anthony
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty chemistry.chemical_compound chemistry business.industry Internal medicine medicine Hematology Newly diagnosed Alvocidib business
Zdroj:	HemaSphere. 3:94
ISSN:	2572-9241
DOI:	10.1097/01.hs9.0000559352.86934.bc
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2fa5242566a77533b8ce42deff9c061f https://doi.org/10.1097/01.hs9.0000559352.86934.bc Zobrazit plný text záznamu Plný text